Yongchun Pan

机构：Incyte (United States) · ORCID：0000-0001-9567-657X

发表论文 85 篇 · 总被引 2378 次 · h-index 26

代表论文

• Microfluidic Synthesis of CuH Nanoparticles for Antitumor Therapy through Hydrogen-Enhanced Apoptosis and Cuproptosis (2024 · ACS Nano · 被引 69)
• Self-Metallized Whole Cell Vaccines Prepared by Microfluidics for Bioorthogonally Catalyzed Antitumor Immunotherapy (2024 · ACS Nano · 被引 23)
• Logic-gated tumor-microenvironment nanoamplifier enables targeted delivery of CRISPR/Cas9 for multimodal cancer therapy (2023 · Acta Pharmaceutica Sinica B · 被引 19)
• Polyamine‐Depleting Hydrogen‐Bond Organic Frameworks Unleash Dendritic Cell and T Cell Vigor for Targeted CRISPR/Cas‐Assisted Cancer Immunotherapy (2025 · Advanced Materials · 被引 18)
• Microneedle‐Loaded Gene‐Editable Nanohybrids Engineer Cancer Cells by Telomere Stress Induction and Metabolic Interference for Enhanced Cuproptosis and Immunotherapy (2024 · Advanced Functional Materials · 被引 16)
• Detecting telomerase activity at the single-cell level using a CRISPR-Cas12a-based chip (2024 · Lab on a Chip · 被引 14)